Concepedia

Henry Gómez

HG

139

Publications

24.5K

Citations

66

H-Index

1991

Active since

Affiliations

Instituto Nacional de Enfermedades Neoplásicas(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

EsSALUD

Vanderbilt University

Henry Gómez is an author at Instituto Nacional de Enfermedades Neoplásicas specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

1991–2024

139

Publications

139

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

José Baselga, Ian Bradbury, Holger Eidtmann et al. · The Lancet · 2012 · 1.3K citations · Full text

, , +5

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Stephen Johnston, John Pippen, Xavier Pivot et al. · Journal of Clinical Oncology · 2009 · 1K citations · Full text

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Olivia Pagani, Meredith M. Regan, Barbara Walley et al. · New England Journal of Medicine · 2014 · 738 citations · Full text

Rows per page

1–5 of 139